266 filings
Page 3 of 14
8-K/A
l4kr3mqmbz42x g60aln
31 Jul 20
Financial Statements and Exhibits
5:00pm
8-K
z8khpwds0t
9 Jul 20
Entry into a Material Definitive Agreement
5:03pm
8-K
mhjyb
29 Jun 20
Provides Conference Call Information
12:00am
8-K
54jmgp6gs
24 Jun 20
Amendments to Articles of Incorporation or Bylaws
4:18pm
8-K
3qt8kb jznipyf
23 Apr 20
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
n9p8dq332ll3
26 Feb 20
Entry into a Material Definitive Agreement
4:59pm
8-K
pls1jn32o
10 Feb 20
Results of Operations and Financial Condition
5:08pm
8-K
gd7wxxwy xjt2
12 Dec 19
Regulation FD Disclosure
8:17am
8-K
yqw395sbex d8
5 Dec 19
Amendments to Articles of Incorporation or Bylaws
5:12pm
8-K
t260p84 wtc1e3ie
19 Nov 19
Entry into a Material Definitive Agreement
7:00am
8-K
jonpaemv7 o9
12 Nov 19
Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2020
5:22pm
8-K
zvg09k
12 Sep 19
Elite Pharmaceuticals Receives FDA Approval for Codeine and Acetaminophen Combo
4:33pm
8-K
v4sc 0c32mmawta
9 Aug 19
Results of Operations and Financial Condition
4:52pm
8-K
fbax6
24 Jun 19
Results of Operations and Financial Condition
12:00am
8-K
s4i nk0oxn09c156
11 Mar 19
Elite Pharmaceuticals Enters into Strategic Marketing Alliance
4:02pm
8-K
koaopkt9gvgxsfy1zy6
12 Feb 19
Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2019
12:00am
8-K
zkmmd80a
3 Jan 19
Regulation FD Disclosure
3:56pm
8-K
q3r80p066w
10 Dec 18
Regulation FD Disclosure
4:00pm
8-K
gi10wdlxczguto6
20 Nov 18
Elite Pharmaceuticals Receives FDA Approval for Hydrocodone and Acetaminophen Combo
4:05pm
8-K
6i2j6v mdiatvj9
9 Nov 18
Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2019
5:01pm